血清miR-31、miR-155和CCL26在溃疡性结肠炎中预后不良的诊断价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

上海市卫计委面上项目(2016460309)


Diagnostic value of serum miR-31, miR-155 and CCL26 in poor prognosis of ulcerative colitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 观察血清miR-31、miR-155和趋化因子配体26(CCL26)在溃疡性结肠炎中预后不良的诊断价值。方法 选择2019年1月—2020年6月在我院收治的溃疡性结肠炎的患者119例,根据Mayo评分将其分为活动期组(65例)和缓解期组(54例);同时根据Mayo评分将活动期组分为轻度亚组(25例),中度亚组(22例)和重度亚组(18例);另选择同期在我院健康体检者45例为对照组。比较各组血清miR-31、miR-155和CCL26水平的变化;分析血清miR-31、miR-155和CCL26水平与溃疡性结肠炎严重程度的关系及影响溃疡性结肠炎预后不良的单因素和多因素分析;评估血清miR-31、miR-155和CCL26水平在2年内溃疡性结肠炎发生预后不良的诊断价值。结果 溃疡性结肠炎活动期组血清miR-31、miR-155和CCL26水平明显高于缓解期组和对照组(P<0.05),而缓解期组明显高于对照组(P<0.01)。血清miR-31、miR-155和CCL26水平随着溃疡性结肠炎严重程度的增加而升高(P<0.05)。单因素和多因素分析发现UCEIS评分>6分,血清miR-31、miR-155和CCL26水平升高是发生溃疡性结肠炎预后不良的独立危险因素(P<0.05)。血清miR-31、miR-155和CCL26水平在诊断溃疡性结肠炎发生预后不良具有较高的诊断效能,联合检测的灵敏度为80%,特异度为99.4%,AUC为0.963明显高于单个指标miR-31(z=2.727,P=0.006)、miR-155(z=3.012,P=0.003)和CCL26(z=2.091,P=0.036)。结论 miR-31、miR-155和CCL26参与了溃疡性结肠炎的发生发展,与溃疡性结肠炎的严重程度有关,联合检测有助于提高对溃疡性结肠炎2年内发生预后不良的诊断价值

    Abstract:

    Objective To observe the diagnostic value of serum miR-31, miR-155 and chemokine C-C motif ligand 26 (CCL26) in the poor prognosis of ulcerative colitis. Methods 119 patients with ulcerative colitis admitted in our hospital from January 2019 to June 2020 were divided into active phase group (65 cases) and remission phase group (54 cases) according to the disease activity. 45 people for physical examination in our hospital were selected as the control group. The serum miR-31, miR-155 and CCL26 levels were compared in each group, the relation between the levels of serum miR-31, miR-155 and CCL26 and the severity of ulcerative colitis were observed, the univariate and multivariate analysis of factors affecting the poor prognosis of ulcerative colitis were also observed, and the diagnostic value of serum miR-31, miR-155 and CCL26 levels were analyzed for the poor prognosis of ulcerative colitis within 2 years. Results The levels of serum miR-31, miR-155 and CCL26 in the active phase group in patients with ulcerative colitis were significantly higher than those in the remission phase group and the control group (P<0.01), while those in the remission phase group were significantly higher than those in the control group (P<0.01). The serum levels of miR-31, miR-155 and CCL26 increased with the severity of ulcerative colitis (P<0.01). The univariate and multivariate analysis showed that the UCEIS score>6 and the increase of serum miR-31, miR-155 and CCL26 levels were independent risk factors for poor prognosis of ulcerative colitis (P<0.05). The levels of serum miR-31, miR-155 and CCL26 had high diagnostic efficacy in the diagnosis of poor prognosis of ulcerative colitis. The sensitivity of combined detection was 80%, the specificity was 99.4%, and the AUC was 0.963, which was significantly higher than that of single indicator miR-31 (z=2.727, P=0.006), miR-155 (z=3.012, P=0.003) and CCL26 (z=2.091, P=0.036).Conclusion The miR-31, miR-155 and CCL26 are involved in the occurrence and development of ulcerative colitis, and are related to the severity of ulcerative colitis. Combined detection is helpful to improve the diagnostic value of poor prognosis of ulcerative colitis within 2 years

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-04-19
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司